These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 26093594)
1. [Cognitive dysfunctions caused by excessive exposure to manganese compounds. Cognitive disturbances in intravenous users of ephedrone (methcathinone) with manganese compounds]. Kałwa A; Habrat B Psychiatr Pol; 2015; 49(2):305-14. PubMed ID: 26093594 [TBL] [Abstract][Full Text] [Related]
2. [Encephalopathy caused by intravenous potassium permanganate used for illegal production of methcathinone (ephedrone) from medicines containing pseudoephedrine]. Habrat B; Baran-Furga H; Sienkiewicz-Jarosz H; Sein Anand J; Poniatowska R Przegl Lek; 2013; 70(8):613-6. PubMed ID: 24466704 [TBL] [Abstract][Full Text] [Related]
3. Characteristic of neuropsychological deficits in patients diagnosed with manganese encephalopathy due to ephedrone use - case series analysis. Kałwa A Psychiatr Pol; 2020 Apr; 54(2):359-380. PubMed ID: 32772066 [TBL] [Abstract][Full Text] [Related]
4. Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study. Selikhova M; Fedoryshyn L; Matviyenko Y; Komnatska I; Kyrylchuk M; Krolicki L; Friedman A; Taylor A; Jäger HR; Lees A; Sanotsky Y Mov Disord; 2008 Nov; 23(15):2224-31. PubMed ID: 18785245 [TBL] [Abstract][Full Text] [Related]
13. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Selikhova M; Tripoliti E; Fedoryshyn L; Matvienko Y; Stanetska H; Boychuk M; Komnatska I; Lees AJ; Sanotsky Y Clin Neurol Neurosurg; 2016 Aug; 147():71-7. PubMed ID: 27310289 [TBL] [Abstract][Full Text] [Related]
14. Irreversible motor impairment in young addicts--ephedrone, manganism or both? Sikk K; Taba P; Haldre S; Bergquist J; Nyholm D; Zjablov G; Asser T; Aquilonius SM Acta Neurol Scand; 2007 Jun; 115(6):385-9. PubMed ID: 17511846 [TBL] [Abstract][Full Text] [Related]
15. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. de Bie RM; Gladstone RM; Strafella AP; Ko JH; Lang AE Arch Neurol; 2007 Jun; 64(6):886-9. PubMed ID: 17562938 [TBL] [Abstract][Full Text] [Related]
16. Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage. Sikk K; Taba P Int Rev Neurobiol; 2015; 120():257-71. PubMed ID: 26070761 [TBL] [Abstract][Full Text] [Related]
17. Parkinsonism due to ephedrone neurotoxicity: a case report. Colosimo C; Guidi M Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409 [No Abstract] [Full Text] [Related]
18. Manganese concentration in patients with encephalopathy following ephedrone use: a narrative review and analysis of case reports. Ordak M; Sloniewicz N; Nasierowski T; Muszynska E; Bujalska-Zadrozny M Clin Toxicol (Phila); 2022 Jan; 60(1):10-17. PubMed ID: 34521308 [TBL] [Abstract][Full Text] [Related]
19. [Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report]. Yildirim EA; Eşsizoğlu A; Köksal A; Doğu B; Baybaş S; Gökalp P Turk Psikiyatri Derg; 2009; 20(3):294-8. PubMed ID: 19757228 [TBL] [Abstract][Full Text] [Related]
20. [The histopathology of ephedrone drug abuse]. Pigolkin IuI; Sherstiuk BV Sud Med Ekspert; 1996; 39(4):26-8. PubMed ID: 9026962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]